News | March 11, 2023
IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Subscribe To Our Newsletter & Stay Updated
